Abstract
P1.01-52 BR-34- Randomized Trial of Durvalumab and Tremelimumab +/- Platinum Chemotherapy in Patients with Metastatic Squamous or Non-Squamous NSCLC
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have